Shattuck raises $75M; Servier inks neuro ASO pact with n-Lorem Foundation

Shattuck Labs launches $75M offering as it advances IBD antibody SL-325; Servier ties up with n-Lorem on rare neuro ASO drugs.Suggested combined headline (≤80 characters):Shattuck raises $75M, Servier inks neuro ASO pact with n-Lorem Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech:…

ENDPOINTS · 2026-06-10

Shattuck Labs initiates $75M public offering: The US biotech {$STTK} is selling over 10.5 million shares for $4 apiece, and issuing pre-funded warrants for certain investors. The offering is set to ...

Source: Endpoints News